Clinical Trial Update: SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective [NA]

View source ↗

Summary

A clinical trial update for the SPAGO study investigating sirolimus-paclitaxel therapy to improve angiographic outcomes in coronary artery disease, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS | Conditions: Coronary Artery Disease, Stenosis Coronary | NA | Status: RECRUITING